Dr. Yellapragada is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2002 Holcombe Blvd
Department Of Hematology Oncology
Houston, TX 77030Phone+1 713-791-1414Fax+1 713-794-7733
Education & Training
Baylor College of MedicineFellowship, Hematology and Medical Oncology, 2005 - 2008
Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Internal Medicine, 2002 - 2005
Madras Medical CollegeClass of 2000
Certifications & Licensure
TX State Medical License 2007 - 2025
PA State Medical License 2024 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting Start of enrollment: 2010 Dec 02
- Study to Evaluate Two Lenalidomide Dose Regimens With Low Dose Dexamethasone for the Treatment Relapsed Multiple Myeloma Start of enrollment: 2010 Aug 01
- Feasibility of a Tele-game-based Exercise (Tele-exergame) Program to Prevent Deconditioning in Hospitalized COVID-19 Patients Start of enrollment: 2021 Jul 05
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Corrigendum to 'Real-World Multicenter Study of PD-1 Blockade in HIV-Associated Classical Hodgkin Lymphoma Across the United States' [Clinical Lymphoma, Myeloma, and L...Kathryn Lurain, Talal El Zarif, Ramya Ramaswami, Amin H Nassar, Elio Adib
Clinical Lymphoma, Myeloma & Leukemia. 2024-12-01 - 1 citationsReal-World Multicenter Study of PD-1 Blockade in HIV-Associated Classical Hodgkin Lymphoma Across the United States.Kathryn Lurain, Talal El Zarif, Ramya Ramaswami, Amin H Nassar, Elio Adib
Clinical Lymphoma, Myeloma & Leukemia. 2024-08-01 - Dyspneic and pink.Christian Inchaustegui, Sarvari Yellapragada, Jack Badawy, Ameer Ahmed, Andrew White
Journal of Hospital Medicine. 2024-07-01
Abstracts/Posters
- Differential Induction Among Younger Patients Diagnosed with Secondary Acute Myelogenous Leukemia Is Feasible By Cytogenetic/Molecular Risk StratificationSarvari Venkata Yellapragada, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- With Equal Access, African Americans with Non-del17p Multiple Myeloma Have Superior Overall Survival, but del17p Still Carries Poor Prognosis across Race: A VA StudySarvari Venkata Yellapragada, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Incidence of Second Primary Malignancies and Association with Treatment in US Veterans with Multiple MyelomaSarvari Venkata Yellapragada, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Lectures
- Predictive Factors for Complete Remission and Survival in AML Patients Failing to Achieve Adequate Bone Marrow Day 14 Blast Eradication2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Vitamin D Deficiency Predicts for Poor Overall Survival in Caucasian but Not African American Patients with Multiple Myeloma2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
Reaching the ‘Unreachable’: The Final Frontier in MedicineJanuary 15th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
